Patent ID: 7754495

Claim:
A method for diagnosing an increased risk of preeclampsia in a subject, the method comprising a) detecting a level of a protein selected from the group consisting of TGF-β 3 , TGF-β type I receptor (ALK-I)(RI), TGF-β type II receptor (R-II), and endoglin in a fluid sample from the subject; and b) comparing the level detected in the subject's fluid sample to a control level obtained from samples of the same fluid taken at the same time of pregnancy from women who did not develop preeclampsia; wherein an increased level of TGF-β 3 , TGF-β type I receptor (ALK-I)(RI), TGF-β type II receptor (R-II), or endoglin in the fluid sample from the subject over that of a control level obtained from samples of the same fluid taken at the same time of pregnancy from women who did not develop preeclampsia indicates an increased risk of preeclampsia.